about
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumoursHyperbaric oxygen modalities are differentially effective in distinct brain ischemia modelsEGFR, PIK3CA, KRAS and BRAF mutations in meningiomasContrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients.Heterogeneity of histopathological presentation of pilocytic astrocytoma - diagnostic pitfalls. A review.Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis.The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications.Commentary on: "Effect of sevoflurane anesthesia on the comprehensive mRNA expression profile of the mouse hippocampus": Postoperative nausea and vomiting conundrum: RNA-seq to the rescue.Pituitary metastases from the oncocytic variant of follicular thyroid carcinoma: a case report and diagnostic dilemmas.MB-02CONTRAST ENHANCEMENT PATTERN IS ASSOCIATED WITH MOLECULAR TYPE OF MEDULLOBLASTOMA TUMOURS AND PREDICTS POOR SURVIVAL FOR PATIENTS.AB thymoma with atypical type A component with delayed multiple lung and brain metastases.Angiocentric glioma: a rare intractable epilepsy-related tumour in children.Papillary glioneuronal tumor with an unusual bilateral intraventricular localization.Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.Secretory meningiomas: immunohistochemical pattern of lectin and ultrastructure of pseudopsammoma bodies.Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions. Ultrastructural study.Ganglion cell tumours in the sella turcica in close morphological connection with pituitary adenomas.Potent Antitumour Effects of Novel Pentabromobenzylisothioureas Studied on Human Glial-derived Tumour Cell Lines.A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumorsTrigone ventricular meningiomas - clinical characteristics, histopathology and results of surgical treatment
P50
Q26739908-3E882C5C-5365-43BC-BE18-37C928182BDDQ28068754-7E74D935-67A3-44A6-93F8-05E57E94D7D0Q33727426-62EF5DFD-E00F-4A9F-A465-FE1A3C985D1AQ35630417-3889891A-7A81-4D27-A858-3E8952868418Q37427414-93645393-72D4-4B7C-B4EE-712AB292A44DQ38879941-F3BB3D48-5C01-40A5-8F4C-8832DD48E021Q38986344-EDA19CAA-AEC1-490B-AD74-DD32F9029B1BQ39254554-5FCC75F7-AF3A-43EE-8FC6-F70C13AB4A63Q41549601-11899B59-7A04-45FE-8254-29EA9FA488F7Q42368547-00AC7C9A-1C34-47E1-A48D-0CD1859727D6Q43428350-0BF4F9AB-24A4-4265-AF54-BF09BEE225C0Q46229086-EA4A6681-5941-425D-9950-3127BF86F3D2Q47139245-A9F9D033-D097-4F02-AD9A-6190B47D0020Q48487028-1304972A-314A-487D-840D-C571EBD8A593Q48517678-857A176C-4B94-4306-9FBD-C1179FD255A6Q50089784-85BCA7D9-9A98-4492-94BC-82FBCE0226E3Q50847730-494C99CC-87C7-42CE-982D-36BEE6A056D3Q51378067-B29862DB-3109-4032-8B8D-A28393290EB0Q53203755-EF1785AB-59A8-4DB8-A2E5-BE43C8A21AECQ53319850-CF7B1611-D08F-479A-990D-1EA90A52066CQ53689520-8BF85606-EA6E-41F1-83C4-CADBF8069405Q55460992-2B5779C9-EEAD-4379-B994-66FDF35757CEQ90319072-3D7254EB-92F0-4BB9-BB02-66845504ED72Q90975952-10F5E52B-84DD-42E7-8E43-64E5D0BDA5F9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ewa Matyja
@ast
Ewa Matyja
@ca
Ewa Matyja
@cs
Ewa Matyja
@en
Ewa Matyja
@gl
Ewa Matyja
@hr
Ewa Matyja
@hsb
Ewa Matyja
@it
Ewa Matyja
@nl
Ewa Matyja
@pl
type
label
Ewa Matyja
@ast
Ewa Matyja
@ca
Ewa Matyja
@cs
Ewa Matyja
@en
Ewa Matyja
@gl
Ewa Matyja
@hr
Ewa Matyja
@hsb
Ewa Matyja
@it
Ewa Matyja
@nl
Ewa Matyja
@pl
prefLabel
Ewa Matyja
@ast
Ewa Matyja
@ca
Ewa Matyja
@cs
Ewa Matyja
@en
Ewa Matyja
@gl
Ewa Matyja
@hr
Ewa Matyja
@hsb
Ewa Matyja
@it
Ewa Matyja
@nl
Ewa Matyja
@pl
P1412
P1559
Ewa Matyja
@pl
P21
P27
P31
P3124
P496
0000-0001-8137-7165